Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
RCP 113 Chap 1-3
| Question | Answer |
|---|---|
| Chemical and physical mixture of 2 or more substances. They contain a solute and a solvent | Solution |
| Either a liquid or a solid that is dissolved in a liquid to form a solution. | Solute |
| Is the liquid that dissolves the solute | Solvent |
| A solution in which the solute being dissolved is a solid | w/v drug solution...Weight/Volume |
| A solution represented by the volume of the liquid solute in the volume of solution. | v/v drug solution...volume/volume |
| Strength of solution as parts of solute per 100 ml of solution | Percentage of Solution |
| A method of expressing the strength of solution as a ratio that represents parts of solute related to parts of solution | Ratio Solution |
| The common system of measurement using miles, feet, ounces, pounds, etc. | English System of Measurement |
| Method for changing units or converting between the English and metric systems | Factor-label method or fraction method |
| A basic unit of mass in the metric system | Gram |
| A basic unit of volume in the metric system | Liter |
| A basic unit of length in the metric system | Meter |
| A system of measurement based on powers of 10 | Metric System of Measurement |
| Strength of solution as parts of solute per 100 ml of solution. | Percentage of solution |
| A statement that compares two ratios | Proportion |
| ac | Before Meals |
| b.i.d. | Twice Daily |
| cap | capsule |
| cc | Cubic Centimeter |
| c (with line on top) | with |
| IM | intramuscular |
| IV | intravenous |
| L | liter |
| ml | milliliter |
| NPO | nothing by mouth |
| pc | After Meals |
| PO | by mouth |
| prn | as needed |
| q. | every |
| q.h. | every hour |
| q.i.d. | four times daily |
| q.2h. | every 2 hours |
| q.3h | every 3 hours |
| q.4h | every 4 hours |
| Rx | TAKE |
| sig | directions |
| stat | immediately |
| tab | tablet or tablets |
| t.i.d. | three times daily |
| ut dict | as directed |
| The chemical neurotransmitter of skeletal muscles, the preganglionic sites of both the parasympathetic and sympathetic nervous system, and the postganglionic sites of the parasympathetic nervous system. | Acetylcholine |
| Also known as cholinergicterase; the enzyme that deactivates acetylcholine | Acetylcholinesterase (AChE) |
| Agents that stimulate the sympathetic nervous system | Adrenergic |
| Receptors of the sympathetic nervous system that include alpha and beta receptors | Adrenergic receptors |
| Nerves that carry impulses to the brain and spinal cord. Also known as sensory nerves | Afferent Nerves |
| Receptors found in the sympathetic nervous system that generally cause vasoconstriction | Alpha receptors |
| Agents that block the effects of the sympathetic nervous system. | Antiadrenergic |
| Agents that block the effects of the parasympathetic nervous system. | Anticholinergic |
| The nervous system that controls the involuntary responses; divided into the parasympathetic and sympathetic branches. | Autonomic Nervous System |
| Receptors found in the sympathetic nervous system that are divided into beta1 and beta 2 subcategories | Beta Receptors |
| Are found primarily in the heart; when stimulated, they cause an increase in rate and force of contraction | Beta 1 receptors |
| Receptors are found primarily in the lungs; when stimulated, they cause bronchodilation | Beta 2 receptors |
| The nervous system comprised of the brain and spinal cord. | Central Nervous System |
| Referring to the parasympathetic nervous system, where acetylcholine is the neurotransmitter substance at all ganglionic sites | Cholinergic |
| Adrenergic receptors found in renal tissue that, when stimulated, relax the renal arteries and therefore increase renal perfusion. | Dopamine Receptors |
| Nerves that carry impulse away from the brain and spinal cord. Also known as motor nerves | Efferent Nerves |
| Nerve cell body outside of the brain and spinal cord | Ganglion |
| Receptors found at the postganglionic site of the parasympathetic nervous system | Muscarinic receptors |
| Receptors found at the skeletal muscles in the somatic system and at all preganglionic sites in the parasympathetic and sympathetic nervous system | Nicotinic Receptors |
| The chemical neurotransmitter substance found a the postganglionic junction of the sympathetic nervous system | Norepinephrine |
| Branch of the peripheral nervous system that maintains normal body functions and homeostasis | Parasympathetic |
| Agent that blocks or antagonizes the effects of the parasympathetic system | Parasympatholytic |
| Agent that stimulates the parasymphathetic system. | Parasympathomimetic |
| Part of the nervous system comprised of all nerves outside the brain and spinal cord; includes the somatic and autonomic nervous systems. | Peripheral Nervous System |
| Process wherein norepinephrine is deactivated at the sympathetic postganglionic sites | Reuptake |
| The part of the nervous system that controls skeletal muscles and therefore voluntary movement | Somatic Nervous System |
| The branch of the peripheral nervous system that prepares the body for stress and emergencies | Sympathetic |
| Agent that blocks or antagonizes the effects of the sympathetic system | Sympatholytic |
| Agent that stimulates the sympathetic system | Sympathomimetic |
| Describing two drugs whose sum effect when given together is equal to the effect from each given separately but at the same time | Additive |
| Drug that activates its receptor upon binding | Agonist |
| Drug that binds to its receptor without activating it | Antagonist |
| Fraction of drug dose that reaches the systemic circulation | Bioavailability |
| Drug use that may result in withdrawal symptoms upon discontinuation; symptoms can be pshychologic or physiologic | Dependence |
| Loss of tissue responsiveness that can occur with drug exposure | Desenstization |
| All inclusive management of a patient's disease | Disease mgmt |
| Agents that induce vomiting | Emetics |
| The route comprising oral, sublingual, nasogastric or rectal routes of drug absorption | Enteral route |
| Elimination of drug that happens after administration but before it reaches the systemic circulation | First pass effect |
| List of drugs stocked by the pharmacy | Formulary |
| Time it takes for the drug concentration to fall to 50% in the body | Half-life |
| Starting dose that is administered to achieve a therapeutic concentration rapidly | Loading Dose |
| Dose given to keep a drug at ta therapeutic level in the blood | Maintenance Dose |
| The route comprising routes that bypass the alimentary tract; injectable | Parenteral Route |
| Actions of the drug on the body | Pharmacodynamics |
| Actions of the body on the drug | Pharmacokinetics |
| Study of drugs and their action on the body | Pharmacology |
| Application of drug therpay to disease treatment | Pharmacotherapy |
| The effect of two drugs given together when one drug has no effect but increases the response of the other drug, which normally has a lesser effect | Potentiation |
| Refers to sites such as albumin where the drug is connected or bound and inactive; influences drug distribution | Protein Binding |
| Refers to drugs that contain two chemical components that may have different activities. | Racemic |
| Target for drugs to act on | Receptor |
| Extent to which a drug acts on one specific site or receptor | Selectivity |
| State reached when input of the drug is equal to output of the drug over the dosing interval | Steady State |
| Refers to drug absorption under the tongue | Sublingual |
| The result when two drugs are given together and their effect is greater than the effect from each given separately | Synergism |
| Having an effect on prenatal development that results in abnormal structure or function | Teratogenic |
| Range of drug concentration in the body in the body in which the drug produces the desired response. | Therapeutic range |
| Study of drugs used to cure, treat, or prevent disease | Therapeutics |
| Decrease in susceptibility to a drug's effect from continued use | Tolerance |
| Study of drugs as it relates to poisonings and environmental toxins. | Toxicology |
| Delivered thru the skin | Transdermal |
Created by:
msmarlo
Popular Pharmacology sets